Ajax Therapeutics last raised $95.0M in its Later Stage VC (Series C) (May 2024).
- ·The complete investor list: 11 names
- ·Watch Ajax Therapeutics: the Monday email on marks, rounds and moves
Ajax Therapeutics funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| May 2024 | Later Stage VC (Series C) | $95.0M | ▮ | ▮ |
| May 2021 | Early Stage VC | $37.4M | ▮ | ▮ |
| Jun 2019 | Early Stage VC | $8.0M | ▮ | ▮ |
Membership and data by Private Market View
Ajax Therapeutics valuation
Ajax Therapeutics's last known valuation is $193 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How much has Ajax Therapeutics raised?
Ajax Therapeutics has raised $143 million across 3 recorded rounds since 2019. The largest was a $95 million Series C in May 2024.
Ajax Therapeutics has filed 3 Form Ds with the SEC since 2019, most recently in May 2024 ($95 million sold to 21 investors).
Comparable companies
Comparable drug discovery names by valuation on PrivateMarketView: Plexium ($200 million), Kinaset Therapeutics ($186 million) and Cambrian Bio ($180 million).
How Ajax Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Ajax Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Ajax Therapeutics
- What is Ajax Therapeutics worth?
- Ajax Therapeutics's last known valuation is $192.5M.
- How much has Ajax Therapeutics raised?
- Ajax Therapeutics has raised $143.0M in total funding across 3 recorded rounds.
- When did Ajax Therapeutics last raise?
- Ajax Therapeutics last raised in May 2024 (Later Stage VC (Series C)), raising $95.0M.